Biotech Q&A; BioSante Announces Completion of Enrollment in LibiGel Safety Study
Point Roberts, WA, LINCOLNSHIRE, Ill –June 7, 2011 –(Investorideas.com newswire.com) Investorideas.com, an investor research portal covering leading sectors including biotech and pharma stocks, features an exclusive Q&A interview and update with Mr. Stephen M. Simes, president and chief executive officer of BioSante Pharmaceuticals. Mr. Simes discusses the significance of the Company’s completion of enrollment in …
Click here to read full Press Release